Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Takahiro Namioka"'
Autor:
Tomohiro Yamaki, Shinichi Oka, Satoshi Iyama, Masanori Sasaki, Rie Onodera, Yuko Kataoka-Sasaki, Takahiro Namioka, Ai Namioka, Masahito Nakazaki, Mitsuhiro Takemura, Ryo Ukai, Takahiro Yokoyama, Yuichi Sasaki, Tatsuro Yamashita, Masato Kobayashi, Misako Yamaguchi, Marina Fukino, Taro Takazawa, Megumi Hayasaka, Takamitsu Owaku, Mika Funakura, Shinji Onodera, Yoichi M. Ito, Masayoshi Kobune, Junji Kato, Sumio Ishiai, Jeffery D. Kocsis, Masaru Odaki, Yasuo Iwadate, Shigeki Kobayashi, Osamu Honmou
Publikováno v:
Interdisciplinary Neurosurgery, Vol 36, Iss , Pp 101927- (2024)
Objective: This study explores safety, feasibility, and potential improvement in functional status after intravenous infusion of mesenchymal stem cells (MSCs) in chronic severe brain injury (BI) patients. Methods: An intravenous infusion of autologou
Externí odkaz:
https://doaj.org/article/625517512187496f8a86d181168f9d61
Autor:
Mari Maeda-Yamamoto, Osamu Honmou, Masanori Sasaki, Akane Haseda, Hiroyo Kagami-Katsuyama, Toshihiko Shoji, Ai Namioka, Takahiro Namioka, Hirotoshi Magota, Shinichi Oka, Yuko Kataoka-Sasaki, Ryou Ukai, Mitsuhiro Takemura, Jun Nishihira
Publikováno v:
Nutrients, Vol 14, Iss 12, p 2446 (2022)
The purple-flesh potato (Solanum tuberosum L.) cultivar “Shadow Queen” (SQ) naturally contains anthocyanins. This randomized, double-blind, placebo-controlled study determines whether ingesting purple potatoes increases the number of mesenchymal
Externí odkaz:
https://doaj.org/article/6794c4789ff64ff290fccb0dbdd8b684
Publikováno v:
Lab Animal. 50:97-107
Animal models are required to study the pathogenesis of brainstem ischemia and to develop new therapeutic approaches to promote functional recovery after ischemia in humans. Few models of brainstem ischemia are available, and they show great variabil
Publikováno v:
Lab animal. 50(4)
Animal models are required to study the pathogenesis of brainstem ischemia and to develop new therapeutic approaches to promote functional recovery after ischemia in humans. Few models of brainstem ischemia are available, and they show great variabil
Autor:
Takahiro Namioka, Masanori Sasaki, Junpei Suzuki, Osamu Honmou, Shinichi Oka, Jeffery D. Kocsis, Yuichi Sasaki, Hiroshi Nagahama, Ai Namioka, Masahito Nakazaki, Yuko Kataoka-Sasaki, Rie Onodera
Publikováno v:
Brain Research. 1695:37-44
Systemic administration of mesenchymal stem cells (MSCs) following cerebral infarction exerts functional improvements. Previous research has suggested potential therapeutic mechanisms that promote neuroprotection and synaptogenesis. These include sec
Autor:
Shinichi Oka, Takahiro Namioka, Masanori Sasaki, Ai Namioka, Sasaki Yuko, Yuichi Sasaki, Masahito Nakazaki, Osamu Honmou, Masafumi Kakizawa
Publikováno v:
Cerebral Blood Flow and Metabolism (Japanese journal of cerebral blood flow and metabolism). 28:281-289
Autor:
Shinichi Oka, Takahiro Namioka, Masanori Sasaki, Masahito Nakazaki, Osamu Honmou, Junpei Suzuki, Jeffery D. Kocsis, Hiroshi Nagahama, Hideyuki Nakamura, Yuko Kataoka-Sasaki, Masahiko Wanibuchi, Yuichi Sasaki, Rie Onodera, Takeshi Mikami, Ai Namioka
Publikováno v:
Journal of Neurosurgical Sciences. 63
Background Intravenous infusion of mesenchymal stem cells (MSCs) derived from adult bone marrow elicits functional recovery in rat stroke models and clinical studies in patients are ongoing. Brain derived neurotrophic factor (BDNF) is a neurotrophic
Autor:
Takahiro Namioka, Sumio Ishiai, Tsutomu Oshigiri, Masanori Sasaki, Tomonori Morita, Ryosuke Hirota, Osamu Honmou, Yuko Kataoka-Sasaki, Satoshi Iyama, Jeffery D. Kocsis, Stephen G. Waxman, Yuichi Sasaki, Shinichi Oka, Rie Onodera, Toshihiko Yamashita, Yoichi M. Ito, Masahito Nakazaki, Ai Namioka, Junji Kato
Publikováno v:
Clinical Neurology and Neurosurgery. 203:106565
Background Although spinal cord injury (SCI) is a major cause of disability, current therapeutic options remain limited. Recent progress in cellular therapy with mesenchymal stem cells (MSCs) has provided improved function in animal models of SCI. We
Autor:
Masanori Sasaki, Osamu Honmou, Jeffery D. Kocsis, Yuichi Sasaki, Ai Namioka, Shinichi Oka, Takahiro Namioka, Masahito Nakazaki, Yuko Kataoka-Sasaki, Junpei Suzuki, Hiroshi Nagahama, Rie Onodera
Publikováno v:
Journal of neurosurgery.
OBJECTIVEIntravenous infusion of mesenchymal stem cells (MSCs) derived from adult bone marrow improves behavioral function in rat models of cerebral infarction. Although clinical studies are ongoing, most studies have focused on the acute or subacute
Autor:
Takahiro Namioka, Masanori Sasaki, Junpei Suzuki, Hiroshi Nagahama, Yuichi Sasaki, Rie Onodera, Yuko Kataoka-Sasaki, Jeffery D. Kocsis, Osamu Honmou, Shinichi Oka, Masahito Nakazaki, Ai Namioka
Publikováno v:
Journal of neurosurgery.
OBJECTIVEMorbidity and mortality in patients with posterior circulation stroke remains an issue despite advances in acute stroke therapies. The intravenous infusion of mesenchymal stem cells (MSCs) elicits therapeutic efficacy in experimental suprate